# International Breast Cancer Study Group

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/international-breast-cancer-study-group/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 85 |
| Citations | 257,054 |
| City | Bern |
| Country | CH |
| Description | International Breast Cancer Study Group is a research organisation in Bern, CH. OpenAlex records 884 works and 257,054 citations for it. 223 researchers list it as their most recent affiliation. |
| Homepage | http://www.ibcsg.org/Pages/default.aspx |
| OpenAlex ID | https://openalex.org/I4210155995 |
| Researchers | 223 |
| ROR ID | https://ror.org/05b2gms10 |
| Type | facility |
| Works | 884 |

## University papers

- [Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial](https://scholariq.org/papers/pembrolizumab-plus-trastuzumab-in-trastuzumab-resistant-advanced-her2-positive/)
- [Second ESMO consensus conference on lung cancer: pathology and molecular biomarkers for non-small-cell lung cancer](https://scholariq.org/papers/second-esmo-consensus-conference-on-lung-cancer-pathology-and-molecular/)
- [Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non–Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers](https://scholariq.org/papers/trastuzumab-emtansine-t-dm1-in-patients-with-previously-treated-her2/)

## University top topics

Showing 8 of 25.

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Estrogen and related hormone effects](https://scholariq.org/topics/estrogen-and-related-hormone-effects/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Cancer Risks and Factors](https://scholariq.org/topics/cancer-risks-and-factors/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.